Terremoto Biosciences, Inc.
Biotechnology · SOUTH SAN FRANCISCO, CA
BiotechnologySEC Form D
Terremoto Biosciences, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 22, 2026, reporting $40,725,000 raised toward a $108,599,999 offering.
Incorporated in Delaware and based in SOUTH SAN FRANCISCO, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Terremoto Biosciences, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Charles BaumExecutive Officer · Director
- James ChristensenExecutive Officer · Director
- Grace LuExecutive Officer
- Reid HuberDirector
- Daniel O'ConnellDirector
- Peter ThompsonDirector
- Michael GollerDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised